APA (7th ed.) Citation

ZD, L., HB, W., XP, L., LY, J., RW, S., XG, W., . . . QF, Y. (2017). Silencing of Prrx2 Inhibits the Invasion and Metastasis of Breast Cancer both In Vitro and In Vivo by Reversing Epithelial-Mesenchymal Transition. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 42(5), 1847. https://doi.org/10.1159/000479542

Chicago Style (17th ed.) Citation

ZD, Lv, et al. "Silencing of Prrx2 Inhibits the Invasion and Metastasis of Breast Cancer Both In Vitro and In Vivo by Reversing Epithelial-Mesenchymal Transition." Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 42, no. 5 (2017): 1847. https://doi.org/10.1159/000479542.

MLA (9th ed.) Citation

ZD, Lv, et al. "Silencing of Prrx2 Inhibits the Invasion and Metastasis of Breast Cancer Both In Vitro and In Vivo by Reversing Epithelial-Mesenchymal Transition." Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, vol. 42, no. 5, 2017, p. 1847, https://doi.org/10.1159/000479542.